Lpl Financial LLC Avidity Biosciences, Inc. Transaction History
Lpl Financial LLC
- $246 Billion
- Q1 2025
A detailed history of Lpl Financial LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 14,046 shares of RNA stock, worth $453,404. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,046
Previous 16,726
16.02%
Holding current value
$453,404
Previous $486,000
14.81%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RNA
# of Institutions
253Shares Held
110MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$366 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$313 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$298 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$278 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$256 Million3.76% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.68B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...